Search Within

Vicky Makker

Formats
  1. Meeting Abstract (142)
  2. Journal Article (110)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (267)
  2. GDMT, Medicine (267)
  3. Gynecologic Medicine Service (267)
  4. Gynecology Disease Management Team (267)
  5. Solid Tumor Oncology Division (267)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (11)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (36)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (74)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (37)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (12)
  6. Wiley Blackwell (9)

More Publishers

Results (267)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Current evidence-based systemic therapy for advanced and recurrent endometrial cancer
    Review

    Gordhandas, S.; Zammarrelli, W. A. 3rd; Rios-Doria, E. V.; Green, A. K.; Makker, V.
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • A phase Ib/II study of lenvatinib and pembrolizumab in advanced endometrial carcinoma (study 111/KEYNOTE-146): Long-term efficacy and safety update
    Journal Article

    Makker, V.; Aghajanian, C.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; Messing, M.; Dutta, L.; Dutcus, C. E.; Huang, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Endometrial carcinosarcoma
    Review

    Bogani, G.; Ray-Coquard, I.; Concin, N.; Ngoi, N. Y. L.; Morice, P.; Caruso, G.; Enomoto, T.; Takehara, K.; Denys, H.; Lorusso, D.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Germline SMARCA4 deletion as a driver of uterine cancer: An atypical presentation
    Journal Article

    Navitski, A.; Al-Rawi, D. H.; Makker, V.; Weigelt, B.; Zamarin, D.; Liu, Y.; Arnold, A. G.; Chui, M. H.; Mandelker, D. L.; Walsh, M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma in the era of molecular classification
    Journal Article

    Zammarrelli, W. A. 3rd; Kim, S. H.; Da Cruz Paula, A.; Rios-Doria, E. V.; Ehmann, S.; Yeoshoua, E.; Hanlon, E. J.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Keynote-C93/GOG-3064/ENGOT-EN15: Phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Slomovitz, B.; Cibula, D.; Gultekin, M.; Mirza, M.; Maćkowiak-Matejczyk, B.; Taylor, A.; Romero, I.; Colombo, N.; Korach, J.; Zhu, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save